MYLK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of MYLK Antibodies for investigating myosin light chain kinase (MYLK) in various cellular processes. MYLK Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MYLK is a critical enzyme involved in the regulation of smooth muscle contraction and plays a significant role in various physiological processes, including vascular tone and cell motility. Dysregulation of MYLK has been implicated in several diseases, making it an important target for research in cardiovascular and smooth muscle disorders. Understanding MYLK function can provide insights into therapeutic strategies for these conditions. MYLK research has revealed its crucial role in maintaining cellular structure and regulating cell migration. Recent studies have highlighted MYLK's involvement in endothelial barrier function and inflammatory responses. Ongoing research continues to uncover new functions of MYLK in cell signaling pathways and tissue homeostasis. Santa Cruz Biotechnology monoclonal antibodies for MYLK support researchers worldwide in advancing our understanding of cardiovascular health and disease mechanisms.